Neuronetics has filed for an $86.3m initial public offering on Nasdaq that will offer exits to corporates Pfizer, General Electric and Ascension.
US-based medical device producer Neuronetics filed for an $86.3m initial public offering on Thursday that will provide exits to pharmaceutical firm Pfizer, conglomerate General Electric and health system Ascension.
Founded in 2003, Neuronetics is working on medical devices that aim to improve the quality of life for patients suffering from psychiatric disorders.
The company’s first commercial product, NeuroStar Advanced Therapy System, acts as a non-invasive treatment that uses a pulsed, MRI-strength magnetic field to stimulate the area of the brain…
